Women's Health

Lactobacillus GR-1 and RC-14 – The solution to the itch of urogenital problems

Posted on by admin

Lactobacillus GR-1 and RC-14 – The solution to the itch of urogenital problems

Jun 2, 2016

Introduction
 

Ladies often shy away when it comes to the topic of urogenital health. In fact, about 75% of women will have at least one episode of vaginal infection in their lifetime. 15-20% of women, without any specific predisposing factors, will experience repeated infections within 3 months of treatment.

 

Similar to the gut, friendly bacteria also colonise the vaginal lining. To restore the microflora balance in the vagina, one can orally consume probiotic strains such as Lactobacillus rhamnosus GR-1and Lactobacillus reuteri RC-14. These two strains have been proven in clinical trials to prevent and relieve urogenital problems in women.

Functions of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14:

  1. Help to maintain a healthy vaginal flora by colonising the vaginal lining and competing ferociously with harmful bacteria and yeast for attachment sites and food.
  2. Produce antimicrobial substances that inhibit the growth of harmful bacteria and yeast.
  3. Create an acidic environment which prevents overgrowth of harmful bacteria and yeast that thrive in an alkaline environment.
  4. Help reduce incidence and recurrence of urogenital problems, namely urinary tract infection, yeast vaginitis and bacterial vaginosis.
  5. Help maintain women’s reproductive and bladder health.
  6. Help relieve symptoms of urogenital infections such as vaginal itch, abnormal vagina discharge, foul-smelling or odourless discharge.

Who should take probiotics Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14?

 

  • Women with recurrent urogenital infections
  • Pregnant women with urogenital infections
  • Women on oral contraceptive pills
  • Antibiotic users
  • Post-menopausal women
  • Women with diabetes
  • Sexually active women
References
 
  1. Martinez, R.C. et al. (2009) Improved cure of bacterial vaginosis with single dose of tinidazole (2g), Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: a randomised, double-blind, placebo-controlled trial. Can. J. Microbiol. 55(2):133-8
  2. Reid, G. et al. (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomised placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 35:131-134
back